Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58,348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Explanation and interpretation of blood transfusion provisions for children with hematological diseases in the national health standard "Guideline for pediatric transfusion"].
Zhao MY, Huang R, Gui R, He QN, Hei MY, Zhu XF, Lu J, Xu XJ, Yuan TM, Zhang R, Wang X, Liu JP, Wang J, Shao ZL, Guo YJ, Wu XY, Chen JR, Chen QR, Guo J, Yang MH. Zhao MY, et al. Among authors: xu xj. Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jan 15;27(1):18-25. doi: 10.7499/j.issn.1008-8830.2410093. Zhongguo Dang Dai Er Ke Za Zhi. 2025. PMID: 39825647 Chinese.
Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria.
Li L, Xu X, Wang W, Huang P, Yu L, Ren Z, Fan J, Zhou J, Zhang L, Wang Z. Li L, et al. Among authors: xu x. J Immunother Cancer. 2025 Jan 16;13(1):e010035. doi: 10.1136/jitc-2024-010035. J Immunother Cancer. 2025. PMID: 39824532 Clinical Trial.
58,348 results
You have reached the last available page of results. Please see the User Guide for more information.